Comparison of the Usefulness of EUS-FNA/B for Histological Diagnosis Using Sonotip Topgain and Acquire.

Comparison of the Usefulness of EUS-FNA/B for Histological Diagnosis Using Sonotip Topgain and Acquire. - Comparison of the Usefulness of EUS-FNA/B for Histological Diagnosis Using Sonotip Topgain and Acquire.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050102

Enrollment

Registered

2023-01-23

Start date

2022-12-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients requiring EUS-FNA/B

Interventions

EUS-FNA/B performed once each on Sonotip Topgain and Acquire

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age18 to 95 2. Those planning EUS-FNA for pancreatic tumors, biliary tumors, lymph nodes, gastric submucosal tumors, etc. 3. Those who, after receiving a full explanation of their participation in this study, have obtained written consent

Exclusion criteria

Exclusion criteria: 1. Plt 50000 mm3 PT(INR) 1.5 2. High risk bleeding for EUS FNA 3. Pregnant patient 4. Doctors doesn't approve.

Design outcomes

Primary

Measure	Time frame
Degree of organization frustration	—

Secondary

Measure	Time frame
Diagnosis, sample amount	—

Countries

Japan

Contacts

Public ContactYusuke Takasaki

Juntendo Nerima hospital Gastroenterology

ytakasa@juntendo.ac.jp03-5923-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026